Octocrylene
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB09535 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 7 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | amenorrhea (disease) | KG + DL |
| 2 | candidiasis | KG + DL |
| 3 | hypogonadotropic hypogonadism with or without anosmia | KG + DL |
| 4 | 46,XY disorder of sex development due to impaired androgen production | KG + DL |
| 5 | Leydig cell hypoplasia due to LH resistance | KG + DL |
| 6 | bone Paget disease | KG + DL |
| 7 | familial adrenal hypoplasia with absent pituitary luteinizing hormone | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.